Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer-Reference-Cited by-同舟云学术

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

Published:2020-12 Issue:12 Volume:31 Page:1725-1733
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lin J.J.,Liu S.V.,McCoach C.E.,Zhu V.W.,Tan A.C.,Yoda S.,Peterson J.,Do A.,Prutisto-Chang K.,Dagogo-Jack I.,Sequist L.V.,Wirth L.J.,Lennerz J.K.,Hata A.N.,Mino-Kenudson M.,Nardi V.,Ou S.-H.I.,Tan D.S.-W.,Gainor J.F.

Funder

Be a Piece of the Solution

Targeting a Cure for Lung Cancer Research Fund

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference39 articles.

1. KIF5B-RET fusions in lung adenocarcinoma;Kohno;Nat Med,2012

2. RET, ROS1 and ALK fusions in lung cancer;Takeuchi;Nat Med,2012

3. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing;Ju;Genome Res,2012

4. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies;Lipson;Nat Med,2012

5. Targeting RET in patients with RET-rearranged lung cancers: results from the global, multicenter RET registry;Gautschi;J Clin Oncol,2017

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. Side Chain Investigation of Imidazopyridazine as a Hinge Binder for Targeting Actionable Mutations of RET Kinase;ACS Medicinal Chemistry Letters;2024-09-03

3. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

4. Development and validation of a novel high-performance liquid chromatography (HPLC) method for the detection of related substances of pralsetinib, a new anti-lung cancer drug;Frontiers in Chemistry;2024-08-21

5. Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”;Cancers;2024-08-19